Ma Jun

[Expert Profile] Ma Jun, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in nasopharyngeal carcinoma radiation therapy in China, working at the Sun Yat-sen University Cancer Center. He has long been dedicated to radiation therapy and comprehensive treatment of nasopharyngeal carcinoma and difficult head and neck tumors, and is a leading figure in nasopharyngeal carcinoma diagnosis and treatment both domestically and internationally.

[Education & Career] Professor Ma Jun graduated from Sun Yat-sen University of Medical Sciences, completed systematic radiation oncology and oncology training at the Sun Yat-sen University Cancer Center, and further studied at famous international cancer centers. He has long served as Vice Director of the Sun Yat-sen University Cancer Center, holding important academic positions including Vice Chair of the Radiation Oncology Branch of the Chinese Medical Association and Chair of the Nasopharyngeal Carcinoma Expert Committee of the Chinese Society of Clinical Oncology (CSCO). He has presided over national-level projects including key grants from the National Natural Science Foundation of China, and is an internationally renowned expert in the field of nasopharyngeal carcinoma.

[Areas of Expertise] Professor Ma specializes in precise staging of nasopharyngeal carcinoma, intensity-modulated radiation therapy, comprehensive chemoradiotherapy, and salvage treatment for recurrent and metastatic nasopharyngeal carcinoma, as well as standardized diagnosis and treatment of difficult head and neck tumors. He has profound expertise in precise target volume delineation, IMRT optimization, and individualized selection of induction chemotherapy and concurrent chemoradiotherapy regimens for nasopharyngeal carcinoma. He excels at developing stratified treatment plans based on EBV-DNA load and staging, significantly improving nasopharyngeal carcinoma patient survival rates while reducing treatment side effects.

[Academic Achievements & Industry Contributions] Professor Ma has led multiple large-scale prospective nasopharyngeal carcinoma clinical trials, first demonstrating that induction chemotherapy combined with chemoradiotherapy can significantly improve survival rates in locally advanced nasopharyngeal carcinoma patients. Related findings were published in top international journals including the New England Journal of Medicine, widely cited by international guidelines, and became the global standard treatment regimen. He has led the establishment of an internationally leading precision nasopharyngeal carcinoma radiation therapy system, driving China's nasopharyngeal carcinoma 5-year survival rate to substantially improve and rank among the highest worldwide, making outstanding contributions to nasopharyngeal carcinoma prevention and treatment not only in China but globally.

[Clinical Practice & Outstanding Contributions] For decades on the front lines of nasopharyngeal carcinoma diagnosis and treatment, Professor Ma has treated tens of thousands of nasopharyngeal carcinoma patients, and his team's annual nasopharyngeal carcinoma patient volume ranks among the highest globally. Leading his team, he has successfully treated numerous advanced nasopharyngeal carcinoma patients, and his treatment model has become a national benchmark for standardized nasopharyngeal carcinoma care. He has received multiple national and international awards, trained a large number of radiation oncology professionals, and is deeply trusted by patients and internationally renowned as an authoritative nasopharyngeal carcinoma expert.

[Honors & Reputation] Professor Ma Jun serves as Executive Vice Director of the Sun Yat-sen University Cancer Center and Chair of the Nasopharyngeal Carcinoma Expert Committee of the Chinese Society of Clinical Oncology (CSCO), among other academic positions. He has presided over national-level projects including the National Key R&D Program, and is an authoritative expert in the field of nasopharyngeal carcinoma in China. He has profound expertise in precision radiation therapy and comprehensive treatment of nasopharyngeal carcinoma and difficult head and neck tumors. He has led multiple large-scale clinical studies that have rewritten international guidelines, with findings published in top international journals and receiving the National Science and Technology Progress Award, bringing China's nasopharyngeal carcinoma diagnosis and treatment standards to a world-leading level. For decades on the clinical front lines, he has helped numerous nasopharyngeal carcinoma patients receive curative treatment, trained a large number of oncology professionals, and is deeply trusted by patients and respected by peers alike.